This finding is consistent with that of Nagai et al. where IFN-γ was required for the tumor inhibitory effects of IL-18 on B16 melanomas using a gene-transfer approach, although the main mechanism reported in this case was via inhibition of tumor angiogenesis [20]. The gene discussed is IFNG; the disease is melanoma.